A phase-III clinical trial to study the effects of vitamin D3 add on therapy with escitalopram in depression.
Phase 3
Completed
- Conditions
- Health Condition 1: F321- Major depressive disorder, singleepisode, moderate
- Registration Number
- CTRI/2020/08/027428
- Lead Sponsor
- Dr P N Suresh Kumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 59
Inclusion Criteria
No antidepressant and antipsychotic exposure for the past 2 months
Serum 25-hydroxy vitamin D levels <12 ng/ml
score of >= 15 on the 17-item Hamilton Depression Rating Scale
Exclusion Criteria
Other psychiatric disorders
Pregnancy and lactation
Concurrent major life-threatening illness like malignancy, cardiac failure, renal failure etc
Suicidal patients
Alcohol and substance abuse and smokers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method